Tag: Nasdaq:MTCR
Metacrine and Its Partners to Present Data at the EASL International...
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with...
Metacrine Announces Date of Fourth Quarter and Full Year 2020 Financial...
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing...